Development of a calcium phosphate-gelatin composite as a bone substitute and its use in drug release

Biomaterials

Volumn 20, Issue 8, 1999, Pages 711-719

  Yaylaoglu M B ^a   Korkusuz, P ^b   Örs, Ü ^b   Korkusuz, F ^a   Hasirci, V ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Bone substitute; Composite; Controlled antibiotic release; Gelatin; Hydroxyapatite

Indexed keywords

ANTIBIOTICS; BIOMATERIALS; BONE; CALCIUM COMPOUNDS; CONTROLLED DRUG DELIVERY; FRACTURE FIXATION;

BONE SUBSTITUTE; CALCIUM PHOSPHATE GELATIN COMPOSITE; CONTROLLED ANTIBIOTIC RELEASE; HYDROXYAPATITE;

IMPLANTS (SURGICAL);

ANTIBIOTIC AGENT; CALCIUM; CALCIUM PHOSPHATE; GELATIN; GENTAMICIN; HYDROXYAPATITE; PHOSPHORUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCOMPATIBILITY; BONE PROSTHESIS; CONTROLLED STUDY; DEGRADATION; DENSITY; DRUG RELEASE; FEMALE; HISTOLOGY; IMPLANT; MEMBRANE; NONHUMAN; PRIORITY JOURNAL; RABBIT; TIBIA;

ANIMALS; ANTI-BACTERIAL AGENTS; BONE SUBSTITUTES; CALCIUM PHOSPHATES; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; FEMALE; GELATIN; GENTAMICINS; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; PROSTHESES AND IMPLANTS; RABBITS; TIBIA; X-RAY DIFFRACTION;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0033119387     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(98)00199-9     Document Type: Article

References (24)

1. Chapman MW, Bucholz R, Cornell C. Treatment of acute fracture with collagen-calcium phosphate graft material. J Bone Jt Surg 1997;79-A:143-7.
2. Gazdag AR, Lane JM, Glaser D, Forster RA. Alternatives to autogenous bone graft: Efficacy and indications. Am Acad Orthop Surg 1995;3:1-8.
3. Glimcher MJ. The nature of the mineral component of bone and the mechanism of calcification. Am Acad of Orthop Surg Instructional Course Lectures 1987;36:49-69.
4. Ducheyne P. Bioceramics: Material characteristics versus in vivo behavior of calcium phosphate ratio. Biomed Mater Res 1987;21: 219-36.
5. Holmes RE. Bone formation and repair. In: Brighton CT, Freidlaender G, Lane CM, editors. Osteoconduction in Hydroxyapatite Based Materials. American Academy of Orthopaedic Surgeons, New York: Wiley, 1994:355-65.
6. Pissiotis E, Spanberg LSW. Biological evaluation of collagen gels containing calcium hydroxide and hydroxyapatite. Endodontics 1990;16:468-73.
7. Boskey AL, Maresca M, Ullrich W, Doty SB, Butler WT, Prince CW. Osteopontin-hydroxyapatite interactions in vitro: Inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone and Mineral 1993;22:147-59.
8. TenHuisen KS, Martin RI, Klimkiewicz M, Brown P. Formation and properties of a synthetic bone composite: Hydroxyapatite-collagen. Biomed Mater Res 1995;29:803-10.
9. Olmo N, Turnay J, Herrera JI, Gavilanes JG, Lizarbe MA. Kinetics of in vivo degradation of sepiolite-collagen complexes: Effects of glutaraldehyde treatment. Biomed Mater Res 1996;30:77-84.
10. Santin M, Huang SJ, Iannace S, Ambrosio L, Nicolais L, Peluso G. Synthesis and characterisation of a new interpenetrated poly (2-hydroxyethylmethacrylate)-gelatin composite polymer. Biomaterials 1996;17:1459-67.
11. Price JS, Tencer AF, Arm DM, Bohach. Controlled release of antibiotics from coated orthopedic implants. Biomed Mater Res 1996;30:281-6.
12. Shinto Y, Uchida A, Korkusuz F, Araki N, Ono K. Calcium hydroxyapatite ceramic used as a delivery system for antibiotics. J Bone Jt Surg 1992;74-B:600-4.
13. Masanobu S, Akira M, Toshikazu M, Nobuhiko S, Kenichi H. Experimental studies on a new bioactive bone cement: Hydroxyapatite composite resin. Biomaterials 1994;15:156-60.
14. Nelson C, Hickman SG, Sleinmer RA. Treatment of experimental osteomyelitis by surgical debridement and the implantation of bioerodable, polyanhydride-gentamicin beads. J Orthop Res 1997;15:249-55.
15. Holmes RE. Bone formation and repair. In: Brighton CT, Freidlaender G, Lane CM, editors. Biodegradable Polymers as Synthetic Bone Grafts. American Academy of Orthopaedic Surgeons, New York: Wiley, 1994:317-53.
16. Petri (III) WH. Evaluation of antibiotic supplemented bone graft in rabbit model. J Oral Maxillofac Surg 1991;49:392-6.
17. Korkusuz F, Uchida A, Shinto Y, Araki N, Inoue K, Ono K. Experimental implant-related osteomyelitis treated by anti-biotic-calcium hydroxyapatite ceramic composites. J Bone Jt Surg 1993;75-B:111-4.
18. Zilch H, Lambiris E. The sustained release of cefotaxim from fibrin-cefotaxim compound in treatment of osteitis. Pharmacokinetic study and clinical results. Arch Orthop Trauma Surg 1986;106:36-41.
19. Osol A, Pratt R, Altschule MD, editors. The United States dispensatory and physicians pharmacology, 26th Ed. Gentamicin. Philadelphia, Toronto: J.B. Lippincott Company, 1983:534-8.
20. Isaacson DM, Kirschbaum J. Assays of antimicrobial substances. In: Demain AL, Solomon NA, editors. Washington, DC: Am Soc Microbiol 1986:410-35.
21. Bocchi G, Valdre G. Physical, chemical and mineralogical characterisation of carbonate-hydroxyapatite concreations of the human pineal gland. Inorg Biochem 1993;49:209-20.
22. Köster K, Karbe E, Kramer H, Heide H, Konig R. Experimental bone replacement with resorbable calcium phosphate ceramic. Langenbecks Arch Chir 1976;341:77-86.
23. Okada H, Toguchi H. Biodegradable microspheres in drug-delivery. Crit Rev Ther Drug Carrier Systems 1995;12:1-99.
24. Pol BJM, Van Wanchem PB, Van Luyu MJA, Van Der Poes L, Bantjes A. In vivo testing of crosslinked polyethers. I. Tissue reactions and biodegradation. Biomed Mater Res 1996; 32:307-20.